We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Trading Rebound Likely to Bolster HSBC's Earnings in Q1
Read MoreHide Full Article
HSBC Holdings (HSBC - Free Report) is scheduled to announce first-quarter 2018 results on May 4, before the market opens. Results, this time, are expected to benefit from reversal in trading activities and decent investment banking performance. However, persistent low rate environment is likely to weigh on the bank’s revenues.
In the last reported quarter, HSBC incurred a loss due to charges related to the U.S. tax reforms and other significant non-recurring items. Notably, the bank witnessed a rise in revenues while higher operating expenses and credit cost acted as headwinds.
Looking at the price performance, HSBC stock has lost 7.7% on the NYSE during the three months ended Mar 31, 2018 compared with 2% decline of the industry it belongs to.
Will HSBC stock be able to rebound post first-quarter earnings release? It majorly depends on whether the firm is able to impress the market with its results.
Factors to Influence Q1 Results
Rebound in trading activities: After three consecutive quarters of witnessing muted activities, volatility is back in the market. In the last two months of the first quarter, the markets experienced significant volatility. The trade war between the United States and China, higher inflation expectation, tightening of monetary policy by the Fed and a sharp sell-off in the tech sector incited volatility. Thus, HSBC is expected to report a rise in trading revenues in the to-be-reported quarter.
Decent investment banking performance: The trend of pocketing solid underwriting fees for debt issuance may have reversed to some extent in the to-be-reported quarter, as rising rates are likely to have slowed down corporates’ involvement in these activities. Thus, HSBC’s debt underwriting fees are expected to decline.
However, strong equity issuances globally are expected to have boosted IPOs and follow-on offerings. So, the related fees are projected to increase for HSBC. Further, a potential rise in fees from increasing M&As in certain sectors will likely lead to a slight rise in advisory revenues for the bank.
Rise in loan demand to support interest income: While a low interest rate environment across several major economies continue hampering interest income growth, increase in loan demand is likely to offset it to some extent. So, HSBC is expected to report a modest improvement in interest income.
Costs to remain manageable: HSBC has been restructuring its operations. These efforts are expected improve the bank’s operating efficiency and trim costs. However, legal and other regulatory expenses are bound to adversely affect its bottom line.
Mitsubishi UFJ Financial Group, Inc. (MUFG - Free Report) is scheduled to announce results on May 15 while both Canadian Imperial Bank of Commerce (CM - Free Report) and The Toronto-Dominion Bank (TD - Free Report) are expected to report on May 24.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Trading Rebound Likely to Bolster HSBC's Earnings in Q1
HSBC Holdings (HSBC - Free Report) is scheduled to announce first-quarter 2018 results on May 4, before the market opens. Results, this time, are expected to benefit from reversal in trading activities and decent investment banking performance. However, persistent low rate environment is likely to weigh on the bank’s revenues.
In the last reported quarter, HSBC incurred a loss due to charges related to the U.S. tax reforms and other significant non-recurring items. Notably, the bank witnessed a rise in revenues while higher operating expenses and credit cost acted as headwinds.
Looking at the price performance, HSBC stock has lost 7.7% on the NYSE during the three months ended Mar 31, 2018 compared with 2% decline of the industry it belongs to.
Will HSBC stock be able to rebound post first-quarter earnings release? It majorly depends on whether the firm is able to impress the market with its results.
Factors to Influence Q1 Results
Rebound in trading activities: After three consecutive quarters of witnessing muted activities, volatility is back in the market. In the last two months of the first quarter, the markets experienced significant volatility. The trade war between the United States and China, higher inflation expectation, tightening of monetary policy by the Fed and a sharp sell-off in the tech sector incited volatility. Thus, HSBC is expected to report a rise in trading revenues in the to-be-reported quarter.
Decent investment banking performance: The trend of pocketing solid underwriting fees for debt issuance may have reversed to some extent in the to-be-reported quarter, as rising rates are likely to have slowed down corporates’ involvement in these activities. Thus, HSBC’s debt underwriting fees are expected to decline.
However, strong equity issuances globally are expected to have boosted IPOs and follow-on offerings. So, the related fees are projected to increase for HSBC. Further, a potential rise in fees from increasing M&As in certain sectors will likely lead to a slight rise in advisory revenues for the bank.
Rise in loan demand to support interest income: While a low interest rate environment across several major economies continue hampering interest income growth, increase in loan demand is likely to offset it to some extent. So, HSBC is expected to report a modest improvement in interest income.
Costs to remain manageable: HSBC has been restructuring its operations. These efforts are expected improve the bank’s operating efficiency and trim costs. However, legal and other regulatory expenses are bound to adversely affect its bottom line.
HSBC currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Schedule of Other Foreign Banks
Mitsubishi UFJ Financial Group, Inc. (MUFG - Free Report) is scheduled to announce results on May 15 while both Canadian Imperial Bank of Commerce (CM - Free Report) and The Toronto-Dominion Bank (TD - Free Report) are expected to report on May 24.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>